Method of detection and disease state management for renal diseases
US7109044B1 · kind B1 · utility
Assignee
Inventors
Key dates
| Filing date | Apr 9, 1999 |
| Grant date | Sep 19, 2006 |
| Priority date | — |
| Expiry date | Apr 9, 2019 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S436/811
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention relates to a method of detection of an early-stage renal disease, comprising determining the concentration of human lipocalin-type prostaglandin D synthase in a body fluid sample taken from a subject and comparing the determined concentration with a reference value set by determining the concentrations of human lipocalin-type prostaglandin D synthase in body fluid samples taken from healthy subjects; and a method of disease state management for a renal disease, comprising determining the concentration of human lipocalin-type prostaglandin D synthase in a body fluid sample taken from a subject and evaluating the glomerular filtration ability of the subject from the determined concentration.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.